At MuriGenics we perform a variety of in vitro toxicity screens and assays for your drug candidates. Performing in vitro cytotoxicity assays prior to animal testing may be a cheaper alternative for initial drug candidate screens. Since many of these tests require cell-based assays, our experience in cell biology enables us to analyze drug candidate treated cells using molecular, biochemical and imaging techniques as well as morphologically. We have expertise in developing protocols as well as adopting protocols from your or cited research, allowing for cost-effective drug candidate screening.